Beyond Dawlish
Hydroxychloroquine tablet is primarily used to treat malaria, a mosquito-borne infectious disease caused by Plasmodium parasites. Additionally, it is prescribed for autoimmune conditions such as rheumatoid arthritis and lupus erythematosus, where it helps alleviate symptoms and reduce disease activity by modulating the immune response. However, its effectiveness in treating conditions like COVID-19 has been widely debated and remains inconclusive.
Malaria: Hydroxychloroquine, along with its predecessor chloroquine, is a key medication for the prevention and treatment of malaria. It is effective against Plasmodium falciparum and other species of the parasite, making it a crucial tool in the global effort to control and eradicate malaria.
Rheumatoid Arthritis: Hydroxychloroquine is commonly prescribed as a disease-modifying antirheumatic drug (DMARD) for the treatment of rheumatoid arthritis. It helps reduce joint inflammation, pain, and swelling associated with the condition, improving overall joint function and quality of life for patients.
Systemic Lupus Erythematosus (SLE): In systemic lupus erythematosus, hydroxychloroquine is used to manage various symptoms, including joint pain, skin rashes, and fatigue. It can also help prevent lupus flares and reduce the risk of organ damage associated with the disease.
Sjögren's Syndrome: Hydroxychloroquine may be prescribed for individuals with Sjögren's syndrome, an autoimmune disorder characterized by dry eyes and mouth, joint pain, and fatigue. It helps alleviate symptoms and improve quality of life by reducing inflammation and autoimmune activity.
